FreeMs Corporation (KOSDAQ:053160)
9,960.00
-140.00 (-1.39%)
At close: Sep 17, 2026
FreeMs Revenue
FreeMs had revenue of 5.54B KRW in the quarter ending June 30, 2026, a decrease of -27.13%. This brings the company's revenue in the last twelve months to 20.95B, up 5.46% year-over-year. In the year 2025, FreeMs had annual revenue of 23.14B with 30.75% growth.
Revenue (ttm)
20.95B
Revenue Growth
+5.46%
P/S Ratio
2.11
Revenue / Employee
551.32M
Employees
38
Market Cap
44.10B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 23.14B | 5.44B | 30.75% |
| Dec 31, 2024 | 17.70B | -5.25B | -22.88% |
| Dec 31, 2023 | 22.94B | -6.69B | -22.57% |
| Dec 31, 2022 | 29.63B | 4.43B | 17.60% |
| Dec 31, 2021 | 25.20B | 6.81B | 37.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Wooree Bio Co.,Ltd | 1.10T |
| CTK Co., Ltd | 100.51B |
| GOODPEOPLE | 70.71B |
| Kyung Nam Pharm | 54.89B |
| JPI Healthcare | 46.86B |
| DYD Co.,LTD. | 44.90B |
| N2Tech Co.,Ltd | 38.74B |
| Russell | 32.45B |